Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

Novo Nordisk

Status: Completed

Conditions: Haemophilia B With Inhibitors; Haemophilia B; Haemophilia A With Inhibitors; Haemophilia A; Congenital Bleeding Disorder

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT01988532

HAEM-4073

U1111-1138-3464 (Other Identifier)

Details and patient eligibility

About

This study is conducted in the United States of America (USA). The aim of the study is to assess the impact of pain on functional impairment and quality of life in adult persons with hemophilia (PWH) with and without inhibitors with joint bleeding.

Enrollment: 381 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult males able to provide consent and complete a survey in English
• Congenital hemophilia A or B with or without inhibitors with any history of joint bleeding or joint pain
• Presentation at the treatment center for a comprehensive annual visit where joint range of motion will be obtained
• Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol)

Exclusion criteria

• Previous participation in this study

Trial design

381 participants in 1 patient group

Adult PWH

Treatment:

Other: No treatment given